Jennifer Chien
Corporate Officer/Principal bei RHYTHM PHARMACEUTICALS, INC.
Vermögen: 296 897 $ am 31.03.2024
Profil
Jennifer L.
Chien is currently the Executive Vice President & Head-North America at Rhythm Pharmaceuticals, Inc. Prior to this, she worked as the Vice President & Head-Genetic Diseases at Genzyme Therapeutics Ltd.
from 2017 to 2020.
She also briefly served as the Chief Commercial Officer at Krystal Biotech, Inc. in 2020.
Ms. Chien received her graduate degree from Harvard University and her undergraduate degree from Massachusetts Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.03.2024 | 6 852 ( 0,01% ) | 296 897 $ | 31.03.2024 |
Aktive Positionen von Jennifer Chien
| Unternehmen | Position | Beginn |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09.11.2020 |
Ehemalige bekannte Positionen von Jennifer Chien
| Unternehmen | Position | Ende |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 16.10.2020 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01.01.2020 |
Ausbildung von Jennifer Chien
| Harvard University | Graduate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| KRYSTAL BIOTECH, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
